Key Dates
6 May 2008
Notification of Acceptances
26 May 2008
Early Registration Cut-off Date
9 June 2008
Late breaking Abstract Submission Date
2 July 2008
Pre & Post Congress Tours
2 July 2008
Social Program Bookings
2 July 2008
Congress Day Tours
9 July 2008
Accommodation Bookings
9 July 2008
Accommodation Deposit deadline
9-10 August 2008
Postgraduate Weekend Courses
10-14 August 2008
Congress Opens
With thanks to
Dr Philip Halloran
Dr. Philip Halloran received his MD from the University of Toronto in 1968. He trained in internal medicine and nephrology in Toronto, and completed his PhD in immunology and immunogenetics in London, England at the London Hospital/University of London in 1976. From 1975 to 1987 he was a clinician and investigator at the Toronto Hospital. From 1987-2003 he was the Director of the DiŽvision of Nephrology & Immunology at the University of Alberta. He is currently the Director of the Alberta Transplant Applied Genomics Centre and is a Professor in the Departments of Medicine and Medical Microbiology & Immunology at the University of Alberta and is the recipient of a Canada Research Chair in Transplant Immunology. Dr. Halloran is the founding Editor-in-Chief of the American Journal of Transplantation, the official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. The journal launched its first issue in May, 2001 and is now first in its field with an impact factor of 6.843.
Dr. Halloran has worked extensively on the regulation of gene expression in transplant organs undergoing rejection, and the effect of tissue injury in transplant organs, and age effects, specifically on evidence for the importance of senescence mechanisms. He has described mechanisms of action of immunosuppressives and the distinct syndrome of antibody-mediated rejection. His recent interests have focused on the diagnostic applications of microarrays in organ transplantation.
He is the Chairman of the Board of Trustees for the Roche Organ Transplant Research Foundation, an independent Swiss charity with the mission to support research projects aiming to advance the science of solid organ transplantation. He is an elected member of the American Society for Clinical Investigation; and has won the Royal College Medal in Medicine, and the Kidney Foundation of Canada Medal of Excellence in Research. Dr. Halloran was named as an Officer of the Order of Canada in July, 2004. Also in 2004, he received the first Paul I. Terasaki Clinical Science Award from the American Society for Histocompatibility & Immunogenetics. In 2005 he received a 'Physician of the Century' Award from the Alberta Medical Association, an Alberta Centennial Medal and The Canadian Society of Transplantation Lifetime Achievement Award. He received the Distinguished Scientist Award from the Canadian Society for Clinical Investigation in October, 2006. In May, 2007 he received the prestigious AST Ernest Hodge Distinguished Achievement Award and in June, 2007 he was elected as a Fellow of the Royal Society of Canada (Life Sciences Division).
Peter Nickerson, MD, FRCPC
Dr. Peter Nickerson is a Transplant Nephrologist and Professor of Internal Medicine and Immunology at the University of Manitoba. He is the Medical Director of the Diagnostic Services of Manitoba Transplant Immunology Laboratory, the Canadian Blood Services Platelet Laboratory, as well as the Director of the Transplant Manitoba - Gift of Life Program located in Winnipeg, Manitoba, Canada.
Dr. Nickerson obtained his MD, Internal Medicine and Nephrology training at the University of Manitoba, followed by a Transplant Research Fellowship at Harvard from 1991-1995. His clinical research program is focused on the mechanisms underlying acute and chronic rejection and developing non-invasive techniques for the diagnosis of rejection.
Dr. Nickerson is currently Past-President of the American Society for Histocompatibility and Immunogenetics (ASHI), and on the Boards of the Canadian Council for Donation & Transplantation (CCDT).
Return to the Plenary Program
